S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 60 of 171

Issue Date	Title / Author(s) / Citation	File
2004-07	Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy Lee, Jae Jin; Kim, Tae Min; Yu, Su Jong; Kim, Dong-Wan; Joh, Yo-han; Oh, Do-Youn; Kwon, Jung Hye; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.34 No.7, pp.400-404	DOI
2005-12	Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I-E/IIE extranodal NK/T-cell lymphoma, nasal type Kim, Tae Min; Park, Yeon Hee; Lee, Sang-Yoon; Kim, Ji-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Kim, Chul Woo; Heo, Dae Seog; Bang, Yung-Jue; Chang, Kee-Hyun; Kim, Noe Kyeong Blood, Vol.106 No.12, pp.3785-3790	DOI
2006-07	Comparative outcomes of reduced intensity and myeloablative allogeneic hematopoietic stem cell transplantation in patients under 50 with hematologic malignancies Kim, Inho; Yoon, Sung Soo; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Tae Min; Kim, Jin-Soo; Kim, Hoon-Gu; Oh, Myoung-Don; Han, Kyou-Sup; Park, Myoung Hee; Park, Seonyang; Kim, Byoung Kook Clin Transplant. 2006 Jul-Aug;20(4):496-503.	link
2008-02	Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer Kim, Yu Jung; Kim, Min A.; Im, Seock-Ah; Kim, Tae Min; Kim, Dong-Wan; Yang, Han-Kwang; Heo, Dae Seog; Lee, Kuhn-Uk; Choe, Kuk Jin; Kim, Noe Kyeong; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Investigation, Vol.26 No.2, pp.152-158	DOI
2008-06	Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea Kim, Tae Min; Kim, Jin Soo; Han, Sae Won; Hong, Yong Sang; Kim, Inho; Ha, Jongwon; Kim, Sang Joon; Chung, Jin Wook; Park, Jae Hyung; Lee, Dongsoon; Park, Seonyang; Kim, Byoung Kook; Kim, Noe Kyeong; Yoon, Sung-Soo Thromb Res. 2009;123(3):436-43. Epub 2008 Jun 24.	link
2009	Clinical predictors of recurrent venous thromboembolism A single institute experience in Korea Kim, Tae Min; Kim, Jin Soo; Han, Sae Won; Hong, Yong Sang; Ha, Jongwon; Chung, Jin Wook; Lee, Dongsoon; Kim, Byoung Kook; Yoon, Sung-Soo; Kim, Noe Kyeong; Park, Seonyang; Park, Jae Hyung; Kim, Sang Joon; Kim, Inho THROMBOSIS RESEARCH; Vol.123 3; 436-443	DOI
2010-01	COMPARISON OF TRADITIONAL ADVANCED CARDIAC LIFE SUPPORT (ACLS) COURSE INSTRUCTION VS. A SCENARIO-BASED, PERFORMANCE ORIENTED TEAM INSTRUCTION (SPOTI) METHOD FOR KOREAN PARAMEDIC STUDENTS Lee, Christopher C.; Im, Mark; Kim, Tae Min; Stapleton, Edward R.; Suh, Gil Joon; Henry, Mark C.; Singer, Adam J.; Kim, Kyuseok JOURNAL OF EMERGENCY MEDICINE; Vol.38 1; 89-92	DOI
2010-05	First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors Kim, Tae Min; Kim, Ki Hwan; Lee, Min Joung; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Chul Woo; Kim, Il Han; Khwarg, Sang In; Heo, Dae Seog Cancer Science, Vol.101 No.5, pp.1199-1203	view file DOI
2011-04	EGFR Gene Copy Number Gain is Related to High Tumor SUV and Frequent Relapse after Adjuvant Chemotherapy in Resected Lung Adenocarcinoma Koh, Youngil; Jang, Bogun; Jeon, Yoon Kyung; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog Japanese Journal of Clinical Oncology, Vol.41 No.4, pp.548-554	DOI
2011-05	Clinicopathologic Characteristics and Outcomes of Patients with Anaplastic Lymphoma Kinase-Positive Advanced Pulmonary Adenocarcinoma Suggestion for an Effective Screening Strategy for These Tumors Koh, Youngil; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Jeon, Yoon Kyung; Chung, Doo Hyun; Kim, Young-Whan; Heo, Dae Seog; Kim, Woo-Ho; Bang, Yung-Jue Journal of Thoracic Oncology, Vol.6 No.5, pp.905-912	DOI
2011-07	MicroRNA-146a Downregulates NF kappa B Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell Lymphoma Paik, Jin Ho; Jang, Ji-Young; Jeon, Yoon Kyung; Kim, Wook Youn; Kim, Tae Min; Heo, Dae Seog; Kim, Chul-Woo CLINICAL CANCER RESEARCH, Vol.17 No.14, pp.4761-4771	DOI
2011-07	Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial Kim, Il Han; Park, Chul-Kee; Heo, Dae Seog; Kim, Chae-Yong; Rhee, Chang Hun; Nam, Do-Hyun; Lee, Seung Hoon; Han, Jung Ho; Lee, Se-Hoon; Kim, Tae Min; Kim, Dong-Wan; Kim, Jeong Eun; Paek, Sun Ha; Kim, Dong Gyu; Kim, In Ah; Kim, Yu Jung; Kim, Jee Hyun; Park, Byung-Joo; Jung, Hee-Won Journal of Neuro-Oncology, Vol.103 No.3, pp.595-602	DOI
2011-08	Clinical dissection of multicentric Castleman disease Shin, Dong-Yeop; Jeon, Yoon Kyung; Hong, Yong-Sang; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Inho; Yoon, Sung-Soo; Heo, Dae Seog; Park, Seonyang; Kim, Byoung Kook Leukemia and Lymphoma, Vol.52 No.8, pp.1517-1522	DOI
2011-09	VEGF Expression is Related to Good Response and Long Progression-free Survival in Gastrointestinal Stromal Tumor Patients Treated With Sunitinib Koh, Youngil; Lee, Hee Eun; Im, Seock-Ah; Kim, Se-Hyung; Kim, Tae Min; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Tae-You; Kim, Woo-Ho; Heo, Dae Seog; Bang, Yung-Jue Diagnostic Molecular Pathology, Vol.20 No.3, pp.143-147	DOI
2011-09	Anaplastic Lymphoma Kinase Translocation A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Soyeon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Kim, Woo-Ho; Kim, Young Tae; Yang, Seok-Chul; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue Journal of Thoracic Oncology, Vol.6 No.9, pp.1474-1480	DOI
2011-11	Clinical significance of tumor-infiltrating FOXP3+T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma Kim, Ki Hwan; Kim, Tae Min; Go, Heounjeong; Kim, Wook Youn; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Khwarg, Sang In; Kim, Chul-Woo; Heo, Dae Seog Cancer Science, Vol.102 No.11, pp.1972-1976	view file DOI
2012-01	Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Kim, Yu-Jung; Han, Sae-Won; Kim, Tae Min; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Noh, Dong-Young; Heo, Dae Seog; Park, In Ae; Bang, Yung-Jue; Ha, Sung Whan Journal of Neuro-Oncology, Vol.106 No.2, pp.303-313	DOI
2012-02	Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer Sim, Sung Hoon; Ahn, Yong-Oon; Yoon, Jieun; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Cancer Science, Vol.103 No.2, pp.155-160	view file DOI
2012-06	Remarkable Tumor Response to Crizotinib in a 14-Year-Old Girl With ALK-Positive Non-Small-Cell Lung Cancer Kim, Su-Jung; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog; Bang, Yung-Jue Journal of Clinical Oncology, Vol.30 No.16, pp.E147-E150	DOI
2012-07	Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer Lee, June Koo; Park, Heae Surng; Kim, Dong-Wan; Kulig, Kimary; Kim, Tae Min; Lee, Se-Hoon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Heo, Dae Seog; Kim, Woo-Ho; Bang, Yung-Jue Cancer, Vol.118 No.14, pp.3579-3586	DOI
2012-08	Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients Park, Heae Surng; Lee, June Koo; Kim, Dong-Wan; Kulig, Kimary; Kim, Tae Min; Lee, Se-Hoon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Heo, Dae Seog Lung Cancer, Vol.77 No.2, pp.288-292	DOI
2012-08	EGFR mutations as a predictive marker of cytotoxic chemotherapy Park, Jin Hyun; Lee, Se-Hoon; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Yang, Seok-Chul; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.77 No.2, pp.433-437	DOI
2012-08	Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation Lee, June Koo; Kim, Tae Min; Koh, Youngil; Lee, Se-Hoon; Kim, Dong-Wan; Jeon, Yoon-Kyung; Chung, Doo Hyun; Yang, Seok-Chul; Kim, Young Tae; Kim, Young-Whan; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.77 No.2, pp.460-463	DOI
2012-09	Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis Bae, Hyun-Mi; Lee, Se-Hoon; Kim, Tae Min; Kim, Dong-Wan; Yang, Seok-Chul; Wu, Hong Gyun; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.77 No.3, pp.572-577	DOI
2012-10	The Changes in MGMT Promoter Methylation Status in Initial and Recurrent Glioblastomas Park, Chul-Kee; Kim, Ja Eun; Kim, Ji Young; Song, Sang Woo; Kim, Jin Wook; Choi, Seung Hong; Kim, Tae Min; Lee, Se-Hoon; Kim, Il Han; Park, Sung-Hye CLINICAL & TRANSLATIONAL ONCOLOGY Vol.5 No.5, pp. 393-397	DOI
2012-12	Definitive Radiotherapy versus Postoperative Radiotherapy for Tonsil Cancer Koo, Tae Ryool; Wu, Hong-Gyun; Hah, J. Hun; Sung, Myung-Whun; Kim, Kwang-Hyun; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae-Seog; Park, Charn Il Cancer Research and Treatment, Vol.44 No.4, pp.227-234	view file DOI
2012-12	Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer Patients Lee, Joo Ho; Wu, Hong-Gyun; Kim, Hak Jae; Kim, Dong-Wan; Lee, Se-Hoon; Kim, Tae Min; Kim, Young Whan; Heo, Dae Seog Cancer Research and Treatment, Vol.44 No.4, pp.242-250	view file DOI
2012-12	Risk Factors for Febrile Neutropenia during Chemotherapy for HIV-Related Lymphoma Park, Jinyong; Kim, Tae Min; Hwang, Jeong-Hwan; Kim, Nak-Hyun; Choe, Pyoeng Gyun; Song, Kyoung-ho; Kim, Eu Suk; Park, Sang-Won; Bin Kim, Hong; Kim, Nam Joong; Park, Wan Beom; Oh, Myoung-don Journal of Korean Medical Science, Vol.27 No.12, pp.1468-1471	DOI
2013-01	Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer Lira, Maruja E.; Kim, Tae Min; Huang, Donghui; Deng, Shibing; Koh, Youngil; Jang, Bogun; Go, Heounjeong; Lee, Se-Hoon; Chung, Doo Hyun; Kim, Woo Ho; Schoenmakers, Eric F. P. M.; Choi, Yoon-La; Park, Keunchil; Ahn, Jin Seok; Sun, Jong-Mu; Ahn, Myung-Ju; Kim, Dong-Wan; Mao, Mao Journal of Molecular Diagnostics, Vol.15 No.1, pp.51-61	DOI
2013-01	Surrogate decision-making in Korean patients with advanced cancer: a longitudinal study Lee, June Koo; Keam, Bhumsuk; An, Ah Reum; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Supportive Care in Cancer, Vol.21 No.1, pp.183-190	DOI
2013-03	Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma Kim, Tae Min; Paeng, Jin Chul; Chun, In Kook; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Lee, Dong Soo; Kim, Chul Woo; Chung, June-Key; Kim, Il Han; Heo, Dae Seog Cancer, Vol.119 No.6, pp.1195-1202	DOI
2013-04	Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer Kim, Soyeon; Kim, Tae Min; Kim, Dong-Wan; Go, Heounjeong; Keam, Bhumsuk; Lee, Se-Hoon; Ku, Ja-Lok; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.8 No.4, pp.415-422	DOI
2013-07	Tumor Burden is Predictive of Survival in Patients With Non-Small-Cell Lung Cancer and With Activating Epidermal Growth Factor Receptor Mutations Who Receive Gefitinib Park, Jin Hyun; Kim, Tae Min; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog Clinical Lung Cancer, Vol.14 No.4, pp.383-389	DOI
2013-07	Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not responding to induction chemotherapy Lim, Yoojoo; Keam, Bhumsuk; Koh, Youngil; Kim, Tae Min; Lee, Se-Hoon; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog; Kim, Kwang Hyun Oral Surgery Oral Medicine Oral Pathology Oral Radiology, Vol.116 No.1, pp.55-60	DOI
2013-08	Erlotinib Versus Gefitinib for Control of Leptomeningeal Carcinomatosis in Non-Small-Cell Lung Cancer Lee, Eunyoung; Keam, Bhumsuk; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Thoracic Oncology, Vol.8 No.8, pp.1069-1074	DOI
2013-09	Clinicopathologic implication of A20/TNFAIP3 deletion in diffuse large B-cell lymphoma: an analysis according to immunohistochemical subgroups and rituximab treatment Paik, Jin Ho; Go, Heounjeong; Nam, Soo Jeong; Kim, Tae Min; Heo, Dae Seog; Kim, Chul-Woo; Jeon, Yoon Kyung Leukemia and Lymphoma, Vol.54 No.9, pp.1934-1941	DOI
2013-09	How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.45 No.3, pp.178-185	view file DOI
2013-09	Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment Huang, Donghui; Kim, Dong-Wan; Kotsakis, Athanasios; Deng, Shibing; Lira, Paul; Ho, Steffan N.; Lee, Nathan V.; Vizcarra, Pamela; Cao, Joan Q.; Christensen, James G.; Kim, Tae Min; Sun, Jong-mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Mao, Mao Genomics, Vol.102 No.3, pp.157-162	DOI
2013-10	Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement Kim, Seon Young; Kim, Hyo Jung; Kang, Hye Jin; Kim, Jin Seok; Eom, Hyeon Seok; Kim, Tae Min; Yoon, Sung-Soo; Suh, Cheolwon; Lee, Dong Soon; Korean Society of Hematology Lymphoma Working Party Journal of Hematology & Oncology Vol.6 No.76, pp.1-12	view file link
2013-11	Clinicopathologic Analysis of ROS1-Rearranged Non-Small-Cell Lung Cancer and Proposal of a Diagnostic Algorithm Go, Heounjeong; Kim, Dong-Wan; Kim, Donghyun; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog; Bang, Yung-Jue; Chung, Doo Hyun Journal of Thoracic Oncology, Vol.8 No.11, pp.1445-1450	DOI
2013-12	Clinical Implications of VEGF, TGF-beta 1, and IL-1 beta in Patients with Advanced Non-small Cell Lung Cancer Kim, Ji-Won; Koh, Youngil; Kim, Dong-Wan; Ahn, Yong-Oon; Kim, Tae Min; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Cancer Research and Treatment, Vol.45 No.4, pp.325-333	DOI
2014-03	Clinical Significance of Downstaging in Patients With Limited-Disease Small-Cell Lung Cancer Go, Se-Il; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Hak Jae; Wu, Hong-Gyun; Chung, Doo Hyun; Heo, Dae Seog Clinical Lung Cancer, Vol.15 No.2, pp.E1-E6	DOI
2014-04	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non-Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor A Meta-analysis Lee, June-Koo; Hahn, Seokyung; Kim, Dong-Wan; Suh, Koung Jin; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog JAMA - Journal of the American Medical Association, Vol.311 No.14, pp.1430-1437	DOI
2014-04	Anti-cancer activity of gemcitabine against natural killer cell leukemia/lymphoma Kim, Tae Min; Kim, Soyeon; Ahn, Yong-Oon; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Leukemia and Lymphoma, Vol.55 No.4, pp.940-943	DOI
2014-06	Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer Lee, Yun-Gyoo; Kim, Inho; Lee, Eunyoung; Bang, Soo-Mee; Kang, Chang Hyun; Kim, Young Tae; Kim, Hak Jae; Wu, Hong-Gyun; Kim, Young Whan; Kim, Tae Min; Lee, Keun-Wook; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Thrombosis and Haemostasis, Vol.111 No.6, pp.1112-1120	view file DOI
2014-08	The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor: A retrospective cohort study Shin, Dong-Yeop; Kim, Dong-Wan; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kang, Chang Hyun; Kim, Young Tae; Heo, Dae Seog Lung Cancer, Vol.85 No.2, pp.320-325	DOI
2014-08	Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog International Journal of Clinical Oncology, Vol.19 No.4, pp.594-600	DOI
2014-10	Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.46 No.4, pp.323-330	view file DOI
2014-11	A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group Kim, Tae Min; Kim, Dong-Wan; Kang, Yoon-Koo; Chung, Jooseop; Song, Hong-Suk; Kim, Hyo Jung; Kim, Byung Soo; Lee, Jong-Seok; Kim, Hawk; Yang, Sung Hyun; Yuh, Young Jin; Bae, Sung Hwa; Hyun, Myung Soo; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog Oncologist, Vol.19 No.11, pp.1129-1130	DOI
2014-11	An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone Nam, Soo Jeong; Go, Heounjeong; Paik, Jin Ho; Kim, Tae Min; Heo, Dae Seog; Kim, Chul Woo; Jeon, Yoon Kyung Leukemia and Lymphoma, Vol.55 No.11, pp.2466-2476	DOI
2014-12	Additional prognostic role of EGFR activating mutations in lung adenocarcinoma patients with brain metastasis: Integrating with lung specific GPA score Lee, Dae-Won; Shin, Dong-Yeop; Kim, Jin Wook; Keam, Bhumsuk; Kim, Tae Min; Kim, Hak Jae; Kim, Dong-Wan; Wu, Hong-Gyun; Paek, Sun Ha; Kim, Young Whan; Heo, Dae Seog; Kim, Dong Gyu; Lee, Se-Hoon Lung Cancer, Vol.86 No.3, pp.363-368	DOI
2014-12	The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer Sim, Sung Hoon; Keam, Bhumsuk; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Journal of Cancer Research and Clinical Oncology, Vol.140 No.12, pp.2135-2142	DOI
2014-12	Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas Paik, Jin Ho; Nam, Soo Jeong; Kim, Tae Min; Heo, Dae Seog; Kim, Chul-Woo; Jeon, Yoon Kyung BMC Cancer, Vol.14 No.1, p. 911	DOI
2015-01	In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer Keam, Bhumsuk; Kim, Soyeon; Ahn, Yong-Oon; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Anticancer Research, Vol.35 No.1, pp.175-182
2015-01	An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients An, Yong Jin; Cho, Hye Rim; Kim, Tae Min; Keam, Bhumsuk; Kim, Jin Wook; Wen, He; Park, Chul-Kee; Lee, Se-Hoon; Im, Seock-Ah; Kim, Jeong Eun; Choi, Seung Hong; Park, Sunghyouk International Journal of Cancer, Vol.136 No.1, pp.162-171	DOI
2015-03	Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL) Kim, Miso; Kim, Tae Min; Kim, Ki Hwan; Keam, Bhumsuk; Lee, Se-Hoon; Kim, Dong-Wan; Lee, Jong Seok; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog Annals of Hematology, Vol.94 No.3, pp.437-444	DOI
2015-04	The impact of molecularly targeted treatment on direct medical costs in patients with advanced non-small cell lung cancer Lee, June-Koo; Kim, Dong-Wan; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Young-Joo; Heo, Dae Seog Cancer Research and Treatment, Vol.47 No.2, pp.182-188	view file DOI
2015-05	Molecular changes associated with acquired resistance to crizotinib in ROS1-rearranged non-small cell lung cancer Song, Ahnah; Kim, Tae Min; Kim, Dong-Wan; Kim, Soyeon; Keam, Bhumsuk; Lee, Se-Hoon; Heo, Dae Seog Clinical Cancer Research, Vol.21 No.10, pp.2379-2387	DOI
2015-06	MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma Go, Heounjeong; Jang, Ji-Young; Kim, Pil-Jong; Kim, Young-Goo; Nam, Soo Jeong; Paik, Jin Ho; Kim, Tae Min; Heo, Dae Seog; Kim, Chul-Woo; Jeon, Yoon Kyung Oncotarget, Vol.6 No.17, pp.15035-15049	DOI
2015-06	Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer Sim, Sung Hoon; Kim, Yu Jung; Kim, Se Hyun; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog; Lee, Jong Seok Journal of Cancer Research and Clinical Oncology, Vol.141 No.6, pp.1073-1081	DOI

1 2 3